Search clinical trials for: cutaneous leishmaniasis topical treatment safety efficacy

Total 114337 results

Cubist Pharmaceuticals LLC

Terminated

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Liver Transplantation | Hepatitis B

New Zealand, United States, Israel, United Kingdom, France, Germany, Spain
Eli Lilly and Company

Completed

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

Social Phobia

United States
Menzies School of Health Research
World Health Organization; Universidade da Paz

Completed

Food Incentives for TB Treatment Compliance in East Timor (FITTCET)

Tuberculosis

Australia
Medical University of Vienna

Completed

Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise

Ocular Physiology | Regional Blood Flow

Austria
Women and Infants Hospital of Rhode Island

Terminated

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Breast Cancer | Ovarian Cancer

United States
Abant Izzet Baysal University

Unknown

A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

Diabetes Mellitus | Hypercholesterolemia | Coronary Heart Disease | Non-Coronary Atherosclerotic Disease

Turkey
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
AstraZeneca

Completed

SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer

Breast Neoplasms

Belgium, Switzerland
Aga Khan University

Completed

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

Hepatic Encephalopathy

Pakistan
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
The New England Center for Headache, P.C.
Ortho-McNeil Neurologics, Inc.

Unknown

Detoxification and Treatment of Subjects With Medication Overuse Headache

Analgesic Rebound Headache

United States
Bispebjerg Hospital

Completed

Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light

Actinic Keratoses

Denmark
Critical Therapeutics

Unknown

Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Ilypsa

Unknown

Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

Kidney Diseases | Renal Insufficiency

United States
Psychiatric Hospital, Hillerod
Amager Hospital; Psychiatric Center Ballerup; Psychogeriatric Unit, CU Hospital... and other collaborators

Terminated

Treatment of Depression in the Elderly

Depression

Denmark
Jacobus Pharmaceutical

Terminated

Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris

Pemphigus Vulgaris

United States
Icahn School of Medicine at Mount Sinai
Allergan

Completed

BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity

Upper Limb Spasticity
Hospital Mutua de Terrassa
Fondo de Investigacion Sanitaria

Terminated

Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia

Pneumonia, Pneumococcal

Spain
University of New Mexico
GlaxoSmithKline

Completed

A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department

Nausea | Vomiting

United States
Instituto Nacional de Cancerologia de Mexico

Unknown

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Non-Hodgkin Lymphoma

Mexico
PowderMed

Completed

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

HSV-2

United States
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
PowderMed

Completed

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

Influenza

United States
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb

Completed

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Schizophrenia | Schizoaffective Disorder | Social Anxiety Disorder

United States
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Tuberculosis

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Memorial Sloan Kettering Cancer Center

Completed

A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery

Prostate Cancer

United States
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company

Completed

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Mesothelioma

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Memorial Sloan Kettering Cancer Center

Completed

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Retinal Consultants Medical Group

Completed

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Macular Degeneration | Choroidal Neovascularization

United States
Eli Lilly and Company

Completed

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

Sepsis

Germany
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company

Completed

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Weight Gain

Italy
Eli Lilly and Company

Completed

Efficacy Study of LY2422347 to Treat Insomnia

Sleep Initiation and Maintenance Disorders

United States
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company

Completed

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Superficial Bladder Cancer

Italy
Eli Lilly and Company

Completed

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
Geha Mental Health Center

Unknown

Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study

Depression

Israel
Boston Scientific Corporation

Completed

Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation

Ventricular Fibrillation | Tachycardia, Ventricular | Heart Failure, Congestive

United States
University Hospital, Saarland
Else Kröner Fresenius Foundation

Unknown

Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression

Inflammation

Germany

3

Subscribe